Xilio Therapeutics
35 hedge funds and large institutions have $16.3M invested in Xilio Therapeutics in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
13.04% less ownership
Funds ownership: 56.55% → 43.52% (-13%)
34% less capital invested
Capital invested by funds: $24.7M → $16.3M (-$8.37M)
Holders
35
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$169K | |
| 2 | +$112K | |
| 3 | +$109K | |
| 4 |
Two Sigma Investments
New York
|
+$53.1K |
| 5 |
Millennium Management
New York
|
+$37K |
Top Sellers
| 1 | -$2.87M | |
| 2 | -$371K | |
| 3 | -$209K | |
| 4 |
Renaissance Technologies
New York
|
-$86.1K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$64.4K |
